Transforming growth factor-β (TGF-β) is a multi-functional
cytokine with a well-described role in the regulation of tissue
fibrosis and regeneration in the liver, kidney and lung. Submandibular gland (SMG) duct
ligation and subsequent deligation in rodents is a classical model for studying salivary gland damage and regeneration. While previous studies suggest that TGF-β may contribute to salivary gland
fibrosis, the expression of TGF-β signaling components has not been investigated in relation to mouse SMG duct
ligation-induced
fibrosis and regeneration following ductal deligation. Following
a 7 day SMG duct
ligation, TGF-β1 and TGF-β3 were significantly upregulated in the SMG, as were TGF-β receptor 1 and downstream Smad family
transcription factors in salivary acinar cells, but not in ductal cells. In acinar cells, duct
ligation also led to upregulation of snail, a Smad-activated
E-cadherin repressor and regulator of epithelial-mesenchymal transition, whereas in ductal cells upregulation of
E-cadherin was observed while snail expression was unchanged. Upregulation of these TGF-β signaling components correlated with upregulation of
fibrosis markers
collagen 1 and
fibronectin, responses that were inhibited by administration of the TGF-β receptor 1 inhibitors
SB431542 or
GW788388. After SMG regeneration following a 28 day duct deligation, TGF-β signaling components and epithelial-mesenchymal transition markers returned to levels similar to non-ligated controls. The results from this study indicate that increased TGF-β signaling contributes to duct
ligation-induced changes in salivary epithelium that correlate with glandular
fibrosis. Furthermore, the reversibility of enhanced TGF-β signaling in acinar cells of duct-ligated mouse SMG after deligation indicates that this is an ideal model for studying TGF-β signaling mechanisms in salivary epithelium as well as mechanisms of
fibrosis initiation and their resolution.